New Treatment for Macular holes
Recent approval of Jetrea (Ocriplasmin) to treat symptomatic VMA (Vitreo Macular Adhesion) has opened up a new era in non surgical management of macular holes. Previously only a hospital based surgery was able to reverse the process of macular hole development but now a new drug can be injected into the eye painlessly in the office and within a few weeks the process reverses back to more normal vision levels.... more
FDA Approves ASRS Leader's ArgusŪ II Artificial Retina
On February 14, the FDA approved the Argus II artificial retina developed by ASRS Executive Committee and Board Member Mark S. Humayun, MD, PhD.
This breakthrough technology is the first ever to offer limited vision to patients with late-stage retinitis pigmentosa (RP).
Second Sight Medical Products (Sylmar, CA) manufactures the Argus II implant, which has 60 electrodes and a tiny camera mounted on eyeglasses to capture images.
The FDA approved Argus II for adults age 25 years or older with severe to profound RP. About 10,000 to 15,000 of the 100,000 Americans with RP will qualify for Argus II. Up to 4,000 patients a year can be treated with the device.
Macular degeneration and Aspirin?
Aspirin and Macular degeneration... is there an increase in the wet form of macular degeneration in those patients taking aspirin? The wet form develops quicker than the dry form. It may only be related to the fact that you are more likely to take aspirin if you have medical problems like stroke or heart attacks in the past and these conditions are more commonly associated with wet age related macular degeneration. ... more
Our practice is committed to answering any questions you may have regarding your medical condition as well as providing information to help you gain additional insight into vitreo-retinal diseases.
Follow the links below to discover more about common diseases treated and managed by the physicians at East Carolina Retina Consultants: